Pages that link to "Item:Q3111177"
From MaRDI portal
The following pages link to Robust EM Continual Reassessment Method in Oncology Dose Finding (Q3111177):
Displaying 4 items.
- Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity (Q2441853) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Time-to-event continual reassessment method incorporating treatment cycle information with application to an oncology phase I trial (Q2931051) (← links)
- A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes (Q6076490) (← links)
